ProShares Ultra NASDAQ Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIB and other ETFs, options, and stocks.

About BIB

BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. The listed name for BIB is ProShares Trust ProShares Ultra Nasdaq Biotechnology. 

Index-Tracked
NASDAQ Composite TR USD
Index-TrackedNASDAQ Composite TR USD
Category
Trading--Leveraged Equity
CategoryTrading--Leveraged Equity
Number of holdings
273
Number of holdings273
Inception Date
Apr 6, 2010
Inception DateApr 6, 2010

BIB Key Statistics

AUM
81.72M
AUM81.72M
Price-Earnings ratio
Price-Earnings ratio
30-Day yield
30-Day yield
Average volume
13.01K
Average volume13.01K
High today
$87.99
High today$87.99
Low today
$82.97
Low today$82.97
Open price
$83.58
Open price$83.58
Volume
14.30K
Volume14.30K
52 Week high
$87.99
52 Week high$87.99
52 Week low
$33.78
52 Week low$33.78
Expense ratio
1.19
Expense ratio1.19

Stock Snapshot

ProShares Ultra NASDAQ Biotech(BIB) stock is priced at $86.73, giving the company a market capitalization of 91.07M.

As of 2026-01-07, ProShares Ultra NASDAQ Biotech(BIB) stock has fluctuated between $82.97 and $87.99. The current price stands at $86.73, placing the stock +4.5% above today's low and -1.4% off the high.

The ProShares Ultra NASDAQ Biotech(BIB)'s current trading volume is 14.3K, compared to an average daily volume of 13.01K.

In the last year, ProShares Ultra NASDAQ Biotech(BIB) shares hit a 52-week high of $87.99 and a 52-week low of $33.78.

In the last year, ProShares Ultra NASDAQ Biotech(BIB) shares hit a 52-week high of $87.99 and a 52-week low of $33.78.

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.